US Patent Litigations are now available. Check here

Explore Mitsubishi Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP1714960Mar 28, 2018Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) Or Disease Attributable To Als1